Abstract
Galanin N-terminal fragment (1–15) [GAL(1–15)] is associated with depression-related and anxiogenic-like effects in rats. In this study, we analyzed the ability of GAL(1–15) to modulate 5-HT1A receptors (5-HT1AR), a key receptor in depression. GAL(1–15) enhanced the antidepressant effects induced by the 5-HT1AR agonist 8-OH-DPAT in the forced swimming test. These effects were stronger than the ones induced by Galanin (GAL). This action involved interactions at receptor level since GAL(1–15) affected the binding characteristics and the mRNA levels of 5-HT1AR in the dorsal hippocampus and dorsal raphe. The involvement of the GALR2 was demonstrated with the GALR2 antagonist M871. Proximity ligation assay experiments indicated that 5-HT1AR are in close proximity with GALR1 and GALR2 in both regions and in raphe RN33B cells. The current results indicate that GAL(1–15) enhances the antidepressant effects induced by 8-OH-DPAT acting on 5-HT1AR operating as postjunctional or as autoreceptors. These results may give the basis for the development of drugs targeting potential GALR1–GALR2–5-HT1AR heteroreceptor complexes linked to the raphe-hippocampal 5-HT neurons for the treatment of depression.
Similar content being viewed by others
References
Albert PR, Lembo P, Storring JM, Charest A, Saucier C (1996) The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology 14(1):19–25. doi:10.1016/S0893-133X(96)80055-8
Albert PR, Le Francois B, Millar AM (2011) Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness. Mol Brain 4:21. doi:10.1186/1756-6606-4-21
Artigas F (2013) Serotonin receptors involved in antidepressant effects. Pharmacol Ther 137(1):119–131. doi:10.1016/j.pharmthera.2012.09.006
Artigas F, Bel N, Casanovas JM, Romero L (1996) Adaptative changes of the serotonergic system after antidepressant treatments. Adv Exp Med Biol 398:51–59
Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38(8):1083–1152 (S0028390899000106 [pii])
Bartfai T, Lu X, Badie-Mahdavi H, Barr AM, Mazarati A, Hua XY, Yaksh T, Haberhauer G, Ceide SC, Trembleau L, Somogyi L, Krock L, Rebek J Jr (2004) Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci USA 101(28):10470–10475. doi:10.1073/pnas.0403802101
Bellido I, Diaz-Cabiale Z, Jimenez-Vasquez PA, Andbjer B, Mathe AA, Fuxe K (2002) Increased density of galanin binding sites in the dorsal raphe in a genetic rat model of depression. Neurosci Lett 317(2):101–105 (S0304394001024466 [pii])
Blier P (2010) Altered function of the serotonin 1A autoreceptor and the antidepressant response. Neuron 65(1):1–2. doi:10.1016/j.neuron.2009.12.028
Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15(7):220–226 (0165-6147(94)90315-8 [pii])
Borroto-Escuela DO, Narvaez M, Marcellino D, Parrado C, Narvaez JA, Tarakanov AO, Agnati LF, Diaz-Cabiale Z, Fuxe K (2010) Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochem Biophys Res Commun 393(4):767–772. doi:10.1016/j.bbrc.2010.02.078
Borroto-Escuela DO, Romero-Fernandez W, Mudo G, Perez-Alea M, Ciruela F, Tarakanov AO, Narvaez M, Di Liberto V, Agnati LF, Belluardo N, Fuxe K (2012) Fibroblast growth factor receptor 1–5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity. Biol Psychiatry 71(1):84–91. doi:10.1016/j.biopsych.2011.09.012
Borroto-Escuela DO, Narvaez M, Di Palma M, Calvo F, Rodriguez D, Millon C, Carlsson J, Agnati LF, Garriga P, Diaz-Cabiale Z, Fuxe K (2014) Preferential activation by galanin 1–15 fragment of the GalR1 protomer of a GalR1–GalR2 heteroreceptor complex. Biochem Biophys Res Commun 452(3):347–353. doi:10.1016/j.bbrc.2014.08.061
Branchek TA, Smith KE, Gerald C, Walker MW (2000) Galanin receptor subtypes. Trends Pharmacol Sci 21(3):109–117 (S0165-6147(00)01446-2 [pii])
Cabello N, Gandia J, Bertarelli DC, Watanabe M, Lluis C, Franco R, Ferre S, Lujan R, Ciruela F (2009) Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. J Neurochem 109(5):1497–1507. doi:10.1111/j.1471-4159.2009.06078.x
Carriba P, Navarro G, Ciruela F, Ferre S, Casado V, Agnati L, Cortes A, Mallol J, Fuxe K, Canela EI, Lluis C, Franco R (2008) Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods 5(8):727–733. doi:10.1038/nmeth.1229
Cervo L, Samanin R (1987) Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. Eur J Pharmacol 144(2):223–229 (0014-2999(87)90523-1 [pii])
Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29(4–5):547–569. doi:10.1016/j.neubiorev.2005.03.008
Detke MJ, Rickels M, Lucki I (1995a) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121(1):66–72
Detke MJ, Wieland S, Lucki I (1995b) Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5-HT1Areceptor antagonists. Psychopharmacology 119(1):47–54
Diaz-Cabiale Z, Narvaez JA, Finnman UB, Bellido I, Ogren SO, Fuxe K (2000) Galanin-(1-16) modulates 5-HT1A receptors in the ventral limbic cortex of the rat. Neuroreport 11(3):515–519
Diaz-Cabiale Z, Parrado C, Vela C, Razani H, Covenas R, Fuxe K, Narvaez JA (2005) Role of galanin and galanin(1–15) on central cardiovascular control. Neuropeptides 39(3):185–190. doi:10.1016/j.npep.2004.12.009
Diaz-Cabiale Z, Parrado C, Fuxe K, Agnati L, Narvaez JA (2007) Receptor-receptor interactions in central cardiovascular regulation. Focus on neuropeptide/alpha(2)-adrenoreceptor interactions in the nucleus tractus solitarius. J Neural Transm 114(1):115–125. doi:10.1007/s00702-006-0559-6
Diaz-Cabiale Z, Parrado C, Narvaez M, Millon C, Puigcerver A, Fuxe K, Narvaez JA (2010) Neurochemical modulation of central cardiovascular control: the integrative role of galanin. EXS 102:113–131
Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C (2000) Serotonin type-1A receptor imaging in depression. Nucl Med Biol 27(5):499–507 (S0969-8051(00)00119-0 [pii])
Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C (2007) Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34(7):865–877. doi:10.1016/j.nucmedbio.2007.06.008
Ferres-Coy A, Santana N, Castane A, Cortes R, Carmona MC, Toth M, Montefeltro A, Artigas F, Bortolozzi A (2013) Acute 5-HT(1)A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions. Psychopharmacology 225(1):61–74. doi:10.1007/s00213-012-2795-9
Fuxe K, Ogren SO, Jansson A, Cintra A, Harfstrand A, Agnati LF (1988) Intraventricular injections of galanin reduces 5-HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto-parietal cortex of the male rat. Acta Physiol Scand 133(4):579–581. doi:10.1111/j.1748-1716.1988.tb08444.x
Fuxe K, Marcellino D, Rivera A, Diaz-Cabiale Z, Filip M, Gago B, Roberts DC, Langel U, Genedani S, Ferraro L, de la Calle A, Narvaez J, Tanganelli S, Woods A, Agnati LF (2008) Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev 58(2):415–452. doi:10.1016/j.brainresrev.2007.11.007
Fuxe K, Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Calvo F, Garriga P, Tena M, Narvaez M, Millon C, Parrado C, Ciruela F, Agnati LF, Narvaez JA, Diaz-Cabiale Z (2012) On the existence and function of galanin receptor heteromers in the central nervous system. Front Endocrinol (Lausanne) 3:127. doi:10.3389/fendo.2012.00127
Garcia-Garcia AL, Newman-Tancredi A, Leonardo ED (2014) 5-HT(1A) (corrected) receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology 231(4):623–636. doi:10.1007/s00213-013-3389-x
Haddjeri N, Blier P, de Montigny C (1998) Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci 18(23):10150–10156
Hamon M, Gozlan H, el Mestikawy S, Emerit MB, Bolanos F, Schechter L (1990) The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties. Ann N Y Acad Sci 600:114–129 (discussion 129–131)
Hedlund PB, Fuxe K (1996) Galanin and 5-HT1A receptor interactions as an integrative mechanism in 5-HT neurotransmission in the brain. Ann N Y Acad Sci 780:193–212
Hedlund PB, Yanaihara N, Fuxe K (1992) Evidence for specific N-terminal galanin fragment binding sites in the rat brain. Eur J Pharmacol 224(2–3):203–205
Hedlund PB, Finnman UB, Yanaihara N, Fuxe K (1994) Galanin-(1–15), but not galanin-(1–29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes. Brain Res 634(1):163–167 (0006-8993(94)90271-2 [pii])
Jans LA, Riedel WJ, Markus CR, Blokland A (2007) Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12(6):522–543. doi:10.1038/sj.mp.4001920
Juhasz G, Hullam G, Eszlari N, Gonda X, Antal P, Anderson IM, Hokfelt TG, Deakin JF, Bagdy G (2014) Brain galanin system genes interact with life stresses in depression-related phenotypes. Proc Natl Acad Sci USA 111(16):E1666–E1673. doi:10.1073/pnas.1403649111
Kehr J, Yoshitake T, Wang FH, Razani H, Gimenez-Llort L, Jansson A, Yamaguchi M, Ogren SO (2002) Galanin is a potent in vivo modulator of mesencephalic serotonergic neurotransmission. Neuropsychopharmacology 27(3):341–356. doi:10.1016/S0893-133X(02)00309-3
Kuteeva E, Hokfelt T, Wardi T, Ogren SO (2008) Galanin, galanin receptor subtypes and depression-like behaviour. Cell Mol Life Sci 65(12):1854–1863. doi:10.1007/s00018-008-8160-9
Lu X, Barr AM, Kinney JW, Sanna P, Conti B, Behrens MM, Bartfai T (2005) A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci USA 102(3):874–879. doi:10.1073/pnas.0408891102
Mannoury la Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L (2006) Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol 70(3):1013–1021. doi:10.1124/mol.106.022756
Millon C, Flores-Burgess A, Narvaez M, Borroto-Escuela DO, Santin L, Parrado C, Narvaez JA, Fuxe K, Diaz-Cabiale Z (2015) A role for galanin N-terminal fragment (1–15) in anxiety- and depression-related behaviors in rats. Int J Neuropsychopharmacol. doi:10.1093/ijnp/pyu064
Misane I, Razani H, Wang FH, Jansson A, Fuxe K, Ogren SO (1998) Intraventricular galanin modulates a 5-HT1A receptor-mediated behavioural response in the rat. Eur J Neurosci 10(4):1230–1240
Mitsukawa K, Lu X, Bartfai T (2008) Galanin, galanin receptors and drug targets. Cell Mol Life Sci 65(12):1796–1805. doi:10.1007/s00018-008-8153-8
Narvaez M, Millon C, Borroto-Escuela D, Flores-Burgess A, Santin L, Parrado C, Gago B, Puigcerver A, Fuxe K, Narvaez JA, Diaz-Cabiale Z (2014) Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions. Brain Struct Funct. doi:10.1007/s00429-014-0788-7
O’Donnell D, Ahmad S, Wahlestedt C, Walker P (1999) Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J Comp Neurol 409(3):469–481. doi:10.1002/(SICI)1096-9861(19990705)409:3<469:AID-CNE10>3.0.CO;2-Q
Razani H, Diaz-Cabiale Z, Fuxe K, Ogren SO (2000) Intraventricular galanin produces a time-dependent modulation of 5-HT1A receptors in the dorsal raphe of the rat. Neuroreport 11(18):3943–3948
Razani H, Diaz-Cabiale Z, Misane I, Wang FH, Fuxe K, Ogren SO (2001) Prolonged effects of intraventricular galanin on a 5-hydroxytryptamine(1A) receptor mediated function in the rat. Neurosci Lett 299(1–2):145–149 (S0304394000017882 [pii])
Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF, Gardier AM, Dranovsky A, David DJ, Beck SG, Hen R, Leonardo ED (2010) 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65(1):40–52. doi:10.1016/j.neuron.2009.12.003
Savitz J, Lucki I, Drevets WC (2009) 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 88(1):17–31. doi:10.1016/j.pneurobio.2009.01.009
Schreiber R, De Vry J (1993) Neuroanatomical basis for the antidepressant-like effects of the 5-HT(1A) receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol 4(6):625–636
Scorza MC, Llado-Pelfort L, Oller S, Cortes R, Puigdemont D, Portella MJ, Perez-Egea R, Alvarez E, Celada P, Perez V, Artigas F (2012) Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. Br J Pharmacol 167(5):1021–1034. doi:10.1111/j.1476-5381.2011.01770.x
Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G (1998) Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 18(18):7394–7401
Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V (1983) Galanin—a novel biologically active peptide from porcine intestine. FEBS Lett 164(1):124–128 (0014-5793(83)80033-7 [pii])
Wang S, He C, Maguire MT, Clemmons AL, Burrier RE, Guzzi MF, Strader CD, Parker EM, Bayne ML (1997) Genomic organization and functional characterization of the mouse GalR1 galanin receptor. FEBS Lett 411(2–3):225–230 (S0014-5793(97)00695-9 [pii])
Weiss JM, Bonsall RW, Demetrikopoulos MK, Emery MS, West CH (1998) Galanin: a significant role in depression? Ann N Y Acad Sci 863:364–382
Acknowledgments
This study was supported by the Junta de Andalucia CVI-6476, UMA PP-05, PP-13, TV3-Marató 090130/31/32 and by and by the Swedish Royal Academy of Sciences (Stiftelsen B. von Beskows Fond and Stiftelsen Hierta-Retzius stipendiefond) and Karolinska Institutets Forskningsstiftelser 2012 and 2013 to D.O.B-E, by Grants from the Swedish Medical Research Council (04X-715), and Hjärnfonden 2012 to K.F.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Millón, C., Flores-Burgess, A., Narváez, M. et al. Galanin (1–15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system. Brain Struct Funct 221, 4491–4504 (2016). https://doi.org/10.1007/s00429-015-1180-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00429-015-1180-y